Cargando…
Use of extracorporeal blood purification therapy (ECBPT) as an adjuvant to high-dose corticosteroids in a severely ill COVID-19 patient with concomitant bacterial infection
COVID-19 presents with a spectrum of severity, ranging from asymptomatic or mild symptoms to those with acute respiratory distress syndrome. Corticosteroids are widely used for their efficacy in reducing inflammatory responses. However, its use may be limited to patients with immunosuppression. An a...
Autores principales: | Lim, Min Xian, Fong, Kean Khang, Yeap, Tat Boon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515465/ https://www.ncbi.nlm.nih.gov/pubmed/34645636 http://dx.doi.org/10.1136/bcr-2021-245639 |
Ejemplares similares
-
Perioperative challenges in managing a morbidly obese patient with COVID-19 undergoing an elective tracheostomy
por: Teah, Kai Ming, et al.
Publicado: (2021) -
Adjuvant corticosteroid therapy for critically ill patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020) -
A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients
por: Niazi, Nicholas S., et al.
Publicado: (2022) -
Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
por: Hahn, Jongsung, et al.
Publicado: (2021) -
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls
por: Ankawi, Ghada, et al.
Publicado: (2018)